Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation

Chest - Tập 141 - Trang 147-153 - 2012
Jonas Bjerring Olesen1,2, Laurent Fauchier3, Deirdre A. Lane1, Sophie Taillandier3, Gregory Y.H. Lip1
1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England
2Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
3Service de Cardiologie, Pôle Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France

Tài liệu tham khảo

Marinigh, 2010, Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis, J Am Coll Cardiol, 56, 827, 10.1016/j.jacc.2010.05.028 Stroke Risk in Atrial Fibrillation Working Group, 2007, Independent predictors of stroke in patients with atrial fibrillation: a systematic review, Neurology, 69, 546, 10.1212/01.wnl.0000267275.68538.8d van Walraven, 2009, Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators, Stroke, 40, 1410, 10.1161/STROKEAHA.108.526988 Olesen, 2011, Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study, BMJ, 342, d124, 10.1136/bmj.d124 Gorin, 2010, Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score = 1, Thromb Haemost, 103, 833, 10.1160/TH09-10-0746 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 The Stroke Prevention in Atrial Fibrillation Investigators, 1992, Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk, Ann Intern Med, 116, 6, 10.7326/0003-4819-116-1-6 Atrial Fibrillation Investigators, 1998, Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials, Arch Intern Med, 158, 1316, 10.1001/archinte.158.12.1316 Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007 Hart, 1999, Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials, Stroke, 30, 1223, 10.1161/01.STR.30.6.1223 Davies, 2001, Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study, Lancet, 358, 439, 10.1016/S0140-6736(01)05620-3 Lip, 2010, Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort, Stroke, 41, 2731, 10.1161/STROKEAHA.110.590257 Frost, 2000, Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation, Am J Med, 108, 36, 10.1016/S0002-9343(99)00415-5 The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography, 1998, Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation, Ann Intern Med, 128, 639, 10.7326/0003-4819-128-8-199804150-00005 Blackshear, 1999, Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications, Stroke, 30, 834, 10.1161/01.STR.30.4.834 Ho, 2011, Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension, J Hum Hypertens, 25, 304, 10.1038/jhh.2010.57 Lip, 2007, Effect of hypertension on anticoagulated patients with atrial fibrillation, Eur Heart J, 28, 752, 10.1093/eurheartj/ehl504 The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators, 1998, Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study, JAMA, 279, 1273, 10.1001/jama.279.16.1273 Singer, 2009, The net clinical benefit of warfarin anticoagulation in atrial fibrillation, Ann Intern Med, 151, 297, 10.7326/0003-4819-151-5-200909010-00003 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Eckman, 2011, Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation, Circ Cardiovasc Qual Outcomes, 4, 14, 10.1161/CIRCOUTCOMES.110.958108 Fang, 2005, Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study, Circulation, 112, 1687, 10.1161/CIRCULATIONAHA.105.553438 Friberg, 2004, Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study), Am J Cardiol, 94, 889, 10.1016/j.amjcard.2004.06.023 Dagres, 2007, Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation, J Am Coll Cardiol, 49, 572, 10.1016/j.jacc.2006.10.047 Diener, 2006, Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Pooled analysis from the SPORTIF III and V studies, Cerebrovasc Dis, 21, 279, 10.1159/000091265 Hughes, 2008, Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data, Thromb Haemost, 99, 295, 10.1160/TH07-08-0508 Fuster, 2006, Europace, 8, 651, 10.1093/europace/eul097